Article Text

Download PDFPDF
Developing the role of midwives as ‘contraceptive champions’ to support early access to effective postnatal contraception for women
  1. Annette Gallimore1,
  2. Alison Craig2,
  3. Sharon Cameron3,
  4. Dona Milne1,
  5. Fatim Lakha1,4
  1. 1 Department of Public Health, NHS Lothian, Edinburgh, UK
  2. 2 Chalmers Sexual Health Centre, Edinburgh, UK
  3. 3 Obstetrics and Gynaecology, Royal Infirmary of Edinburgh, Edinburgh, UK
  4. 4 Communicable Disease Policy Research Group, Department of Global Health and Development, London School of Hygiene & Tropical Medicine Faculty of Public Health Mahidol University, Bangkok, Thailand
  1. Correspondence to Annette Gallimore, Department of Public Health, NHS Lothian, Edinburgh EH1 3EG, UK; annette.gallimore{at}


Objective To evaluate the acceptability of the new contraceptive champion role to the first hospital and community midwives in NHS Lothian trained in this role.

Design Health service evaluation.

Population Hospital and community midwives trained as contraceptive champions, NHS Lothian, Scotland, UK.

Methods Qualitative research: 1:1 semi-structured interviews (baseline and follow-up) with five contraceptive champions.

Main outcome measure Qualitative data on views of the new contraceptive champions on the first 6 months of the role.

Results All contraceptive champions stated increased confidence in their knowledge of postnatal contraception. They reported that women had not questioned the role of midwives in inserting contraceptive implants postnatally in hospital and at home. Midwife colleagues and hospital doctors had been supportive.

Conclusion The new role of contraceptive champion is reported by midwives to have been well received in its first year by women, the midwives themselves and their healthcare colleagues.

  • contraception
  • long acting reversible contraception
  • LARC
  • contraceptive champion
  • hospital midwife
  • community midwife
  • postnatal
  • contraceptive implant
  • intrauterine contraception
  • progestogen only injectable
  • progestogen only pill

Statistics from


  • Contributors AG designed the research question and the study approach with input from AC, DM, SC and FL. AG, AC, DM, SC and FL all contributed to the design of data collection resources and approved AG’s methods for data analysis and interpretation. AG wrote the first draft of the manuscript and all authors read and revised subsequent drafts for intellectual content. AG, SC, DM, AC and FL all approved the final draft of the manuscript for publication and accept responsibility for the article as published.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Ethics approval The South East Scotland Research Ethics Service committee officer reviewed the protocol and confirmed that ethical approval was not required for this health service evaluation.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Highlights from this issue
    British Medical Journal Publishing Group